Both in Pharmaceuticals
Dianthus Therapeutics vs Liquidia
Over the past year DNTH returned +158.5% and LQDA returned +69.8%; their daily moves had a correlation of 0.15.
DNTH +158.5% LQDA +69.8%Growth of $1, one year, split-adjusted
| Metric | DNTH | LQDA |
|---|---|---|
| Price | $85.81 | $47.38 |
| Market cap | $4.80B | $4.24B |
| Today | +3.76% | +12.27% |
| 1 month | +0.5% | +82.9% |
| 6 months | −5.1% | +12.4% |
| Year to date | +108.2% | +37.4% |
| 1 year | +152.2% | +87.9% |
| Revenue growth (YoY) | +294.3% | +1842.7% |
| Gross margin | 100.0% | 93.3% |
| Net margin | −6598.6% | 43.5% |
| P/E (TTM) | — | 30.6× |
| Price / sales | 2,520.9× | 9.4× |
| Net cash | $886.8M | $108.1M |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 191.5% |
| Short % of float | 18.4% | 26.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).